Biofrontera Inc. Announces Special Meeting for Share Increase Proposal

TL;DR

<b>Biofrontera Inc. is holding a virtual special meeting on April 24, 2024, to vote on increasing authorized shares from 15 million to 35 million.</b>

AI Summary

Biofrontera Inc. (BFRIW) filed a Proxy Statement (DEF 14A) with the SEC on March 21, 2024. Biofrontera Inc. will hold a special meeting of stockholders on April 24, 2024, at 10:00 AM ET. The meeting will be conducted virtually via live webcast. The primary purpose is to approve an amendment to increase authorized common stock from 15,000,000 to 35,000,000 shares. A proposal to adjourn the meeting will also be presented if needed for the share increase approval. The record date for determining eligible stockholders is March 18, 2024.

Why It Matters

For investors and stakeholders tracking Biofrontera Inc., this filing contains several important signals. The proposed increase in authorized shares is crucial for Biofrontera's future financing and strategic initiatives, potentially impacting its ability to raise capital or execute mergers and acquisitions. The virtual format and the adjournment proposal suggest a proactive approach to ensure shareholder participation and secure the necessary votes for the share increase, indicating its importance to the company's strategy.

Risk Assessment

Risk Level: low — Biofrontera Inc. shows low risk based on this filing. The filing is a routine proxy statement for a shareholder meeting, with no immediate financial or operational performance indicators presented.

Analyst Insight

Stockholders should review the proxy materials carefully to understand the implications of the proposed increase in authorized shares and vote accordingly.

Key Numbers

• 2024-04-24 — Special Meeting Date (Date of the Special Meeting of Stockholders)
• 15,000,000 — Current Authorized Shares (Number of authorized common stock shares before amendment)
• 35,000,000 — Proposed Authorized Shares (Number of authorized common stock shares after proposed amendment)
• 2024-03-18 — Record Date (Date to determine stockholders eligible to vote)

Key Players & Entities

• Biofrontera Inc. (company) — Registrant name
• April 24, 2024 (date) — Date of Special Meeting
• 10:00 AM ET (time) — Time of Special Meeting
• 15,000,000 (dollar_amount) — Current authorized shares
• 35,000,000 (dollar_amount) — Proposed authorized shares
• March 18, 2024 (date) — Record Date for Special Meeting

FAQ

Industry Context

Biofrontera Inc. operates in the pharmaceutical preparations industry, focusing on dermatological treatments.

Regulatory Implications

The filing is a proxy statement (DEF 14A) under the Securities Exchange Act of 1934, requiring specific disclosures for shareholder meetings.

What Investors Should Do

1. Review the proxy statement for details on the Share Increase Proposal.
2. Determine eligibility to vote based on the March 18, 2024 record date.
3. Participate in the virtual Special Meeting on April 24, 2024, or submit proxy votes.

Key Dates

• 2024-04-24: Special Meeting of Stockholders — To vote on increasing authorized shares and potential adjournment.
• 2024-03-18: Record Date — Determines stockholders eligible to vote at the Special Meeting.

Year-Over-Year Comparison

This filing is a DEF 14A, a proxy statement, and does not contain comparative financial data from a previous filing period.

Key Financial Figures

• $0.001 — 3 shares of our common stock, par value $0.001 per share (our &ldquo;Common Stock&rdqu

Filing Documents

• formdef14a.htm (DEF 14A) — 206KB
• formdef14a_001.jpg (GRAPHIC) — 2KB
• formdef14a_002.jpg (GRAPHIC) — 2KB
• formdef14a_003.jpg (GRAPHIC) — 7KB
• formdef14a_004.jpg (GRAPHIC) — 247KB
• formdef14a_005.jpg (GRAPHIC) — 228KB
• 0001493152-24-010706.txt (&nbsp;) — 877KB

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 11 OTHER MATTERS 13 Appendix A &ndash; Form of Increase to Authorized Common Stock Amendment QUESTIONS AND ANSWERS Q: Why am I receiving these materials? A: We have sent you these proxy materials because the Board of Directors is soliciting your proxy to vote at the Special Meeting, including at any adjournments or postponements of the Special Meeting. Q: What proposals are being presented for a stockholder vote at the Special Meeting? A: The following proposals are being presented for stockholder vote at the Special Meeting: Proposal No. 1 - approval of an amendment to our Amended and Restated Certificate of Incorporation, to increase the number of authorized shares of our common stock from 15,000,000 to 35,000,000; and Proposal No. 2 - approval of a proposal to adjourn the Special Meeting to a later date or dates, if necessary or appropriate, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of Proposal No. 1. Q: How does the Board of Directors recommend that I vote? A: The Board of Directors unanimously recommends that you vote &ldquo; FOR &rdquo; Proposals No. 1 and No. 2. Q: What does it mean to vote by proxy? A: When you vote &ldquo;by proxy,&rdquo; you grant another person the power to vote stock that you own. If you vote by proxy in accordance with this proxy statement, you will have designated the following individuals as your proxy holders for the Special Meeting: Hermann Luebbert, Fred Leffler and Daniel Hakansson. Any proxy given pursuant to this solicitation and received in time for the Special Meeting will be voted in accordance with your specific instructions. If you provide a proxy, but you do not provide specific instructions on how to vote on each proposal, the proxy holder will vote your shares &ldquo;FOR&rdquo; Proposals No. 1 and Proposal No. 2. Wit

View Full Filing

View this DEF 14A filing on SEC EDGAR